Unknown

Dataset Information

0

Effects of human immunodeficiency virus and metabolic complications on myocardial nutrient metabolism, blood flow, and oxygen consumption: a cross-sectional analysis.


ABSTRACT: In the general population, peripheral metabolic complications (MC) increase the risk for left ventricular dysfunction. Human immunodeficiency virus infection (HIV) and combination anti-retroviral therapy (cART) are associated with MC, left ventricular dysfunction, and a higher incidence of cardiovascular events than the general population. We examined whether myocardial nutrient metabolism and left ventricular dysfunction are related to one another and worse in HIV infected men treated with cART vs. HIV-negative men with or without MC.Prospective, cross-sectional study of myocardial glucose and fatty acid metabolism and left ventricular function in HIV+ and HIV-negative men with and without MC. Myocardial glucose utilization (GLUT), and fatty acid oxidation and utilization rates were quantified using 11C-glucose and 11C-palmitate and myocardial positron emission tomography (PET) imaging in four groups of men: 23 HIV+ men with MC+ (HIV+/MC+, 42 ± 6 yrs), 15 HIV+ men without MC (HIV+/MC-, 41 ± 6 yrs), 9 HIV-negative men with MC (HIV-/MC+, 33 ± 5 yrs), and 22 HIV-negative men without MC (HIV-/MC-, 25 ± 6 yrs). Left ventricular function parameters were quantified using echocardiography.Myocardial glucose utilization was similar among groups, however when normalized to fasting plasma insulin concentration (GLUT/INS) was lower (p < 0.01) in men with metabolic complications (HIV+: 9.2 ± 6.2 vs. HIV-: 10.4 ± 8.1 nmol/g/min/μU/mL) than men without metabolic complications (HIV+: 45.0 ± 33.3 vs. HIV-: 60.3 ± 53.0 nmol/g/min/μU/mL). Lower GLUT/INS was associated with lower myocardial relaxation velocity during early diastole (r = 0.39, p < 0.001).Men with metabolic complications, irrespective of HIV infection, had lower basal myocardial glucose utilization rates per unit insulin that were related to left ventricular diastolic impairments, indicating that well-controlled HIV infection is not an independent risk factor for blunted myocardial glucose utilization per unit of insulin.NIH Clinical Trials NCT00656851.

SUBMITTER: Cade WT 

PROVIDER: S-EPMC3258269 | BioStudies | 2011-01-01

SECONDARY ACCESSION(S): NCT00656851

REPOSITORIES: biostudies

Similar Datasets

2011-01-01 | S-EPMC3253498 | BioStudies
1000-01-01 | S-EPMC3416696 | BioStudies
1000-01-01 | S-EPMC5915485 | BioStudies
2015-01-01 | S-EPMC4289018 | BioStudies
2020-01-01 | S-EPMC7457052 | BioStudies
1000-01-01 | S-EPMC1100777 | BioStudies
2020-01-01 | S-EPMC7140436 | BioStudies
1992-01-01 | S-EPMC1132927 | BioStudies
2019-01-01 | S-EPMC6616532 | BioStudies
2019-01-01 | S-EPMC6405673 | BioStudies